Therapies

How Gene Therapy Could Cure Cocaine Addiction

1 month ago   |   By Discovery's Edge

Cocaine is like a roller coaster in powder form. First, there is the intense rush of euphoria, excitement, and invincibility. Then, almost as quickly, there is the crash into depression, edginess and cravings for more. A single hit is all it takes, flooding the brain with the feel-good chemical dopamine, subverting the neurons that control learning and reward, and priming the nervous system for the next ride.
It is estimated that 1 in 5 people who try cocaine will become dependent on it at some point in their life. Unlike addiction to opioids, there is no medication to treat addiction to...
Read more ...

 


Search by Tags

   Therapies      Gene      Drug      Engineering      Clinical      Gene Therapy      Drugs      Chemical      Chemicals      Enzymes      Brain      Genes      Research      Featured      Rotator      Adeno-associated virus      Cholinesterases      Cocaine addiction      Computer-Aided Molecular Design Laboratory      Gene therapy      Ghrelin      Liyi Geng      Michael Hooten      Stephen Brimijoin      Viral vector      Yuan-Ping Pang  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Convalescent Plasma: A Therapy for COVID-19?

Convalescent Plasma: A Therapy for COVID-19?

To develop a treatment for patients with COVID-19, researchers around the world are steadfastly exploring numerous angles, including testing existing antiviral drugs and new... Read more ...

Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests

Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests

The financial markets may remain volatile but Keros Therapeutics managed to raise more money in its public market debut than it had initially planned. Late Tuesday the... Read more ...

Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers

Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers

Inovio Pharmaceuticals, one of the biotechs developing a vaccine to prevent COVID-19, has received the FDA's OK to start testing its candidate in healthy volunteers. The... Read more ...

Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug

Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug

Sage Therapeutics is cutting workers who sell its only commercialized drug in a corporate reorganization that it says allows it to focus on clinical-stage compounds, including... Read more ...

Creating Consistent Value in Biotech Without Diluting Stakeholders

Creating Consistent Value in Biotech Without Diluting Stakeholders

One of the greatest challenges for pre-commercial biotech companies is consistently generating capital necessary for operating costs and for R&D of new products that provide... Read more ...

Interactive, Online Xcelerating Life Sciences Boston Event Set for May 13

Interactive, Online Xcelerating Life Sciences Boston Event Set for May 13

In the Boston biotech hub, much progress has been made advancing digital health, but significant scientific, technological, financial, and regulatory challenges remain. Join us... Read more ...

Millendo May Restructure After Prader-Willi Drug Fails Pivotal Test

Millendo May Restructure After Prader-Willi Drug Fails Pivotal Test

Millendo Therapeutics is considering a corporate reorganization after its lead drug, an investigational treatment for a rare genetic condition characterized by unrelenting... Read more ...

Menlo's Itching Drug Racks Up Two More Trial Failures, Program Ends

Menlo's Itching Drug Racks Up Two More Trial Failures, Program Ends

An itching drug that was a key part of the merger of Menlo Therapeutics and Foamix Pharmaceuticals has failed two late-stage studies, leading to a halt on further development... Read more ...

Premier Biomedical Realigns Business to Eliminate Convertible Debt, Cancel...

Premier Biomedical Realigns Business to Eliminate Convertible Debt, Cancel Reverse Split & Fund Covid-19 R&D

Jackson Center, PA, April 6, 2020 - Premier Biomedical, Inc. announced a multi-faceted agreement to eliminate the Convertible Notes as an obligation of Premier, cancel the... Read more ...

GSK, Vir Team Up in COVID-19 Pact Aiming to Reach the Clinic in Months

GSK, Vir Team Up in COVID-19 Pact Aiming to Reach the Clinic in Months

GlaxoSmithKline has agreed to invest $250 million in infectious disease specialist Vir Biotechnology to launch a COVID-19 R&D alliance that the companies say could advance two... Read more ...